Filip Borgions
Chief Tech/Sci/R&D Officer presso ARGENX SE
Profilo
Filip Borgions is currently the Global Head-Technical Operations at argenx SE since 2015.
Previously, he worked as a Principal at Thrombogenics, Inc. Dr. Borgions has an undergraduate and doctorate degree from Katholieke Universiteit Leuven.
Posizioni attive di Filip Borgions
| Società | Posizione | Inizio |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Precedenti posizioni note di Filip Borgions
| Società | Posizione | Fine |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Formazione di Filip Borgions
| Katholieke Universiteit Leuven | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Aziende private | 1 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Filip Borgions
